Polypore price target lowered to $44 from $50 at Needham Needham believes Polypore hosted an informative analyst event where it clarified the efficiency advantages of the Celgard brand over the competition. The firm thinks it should just be a matter time when volumes improve and reiterates a Strong Buy rating on the stock. Needham lowered price target reflects the company's revised guidance issued on Tuesday
News For PPO From The Last 14 Days
Check below for free stories on PPO the last two weeks.
